Loading
Steven Le Gouill is a lymphoma specialist who leads the Institut Curie hospitals.
Steven Le Gouill is Director of the Institut Curie Hospital Group in Paris and a haematologist. His specialisms are lymphoma, mantle cell lymphoma and hospital leadership. He is a lymphoma trialist known for mantle cell lymphoma studies with the LYSA group. His papers include the long-term follow-up of rituximab maintenance in young patients with mantle cell lymphoma in the LYMA trial, the final results of a phase II study of acalabrutinib monotherapy in relapsed or refractory mantle cell lymphoma, and a Blood comparison of obinutuzumab and rituximab for transplant-eligible patients with mantle cell lymphoma. His publications are listed on PubMed.
Shares LYSA (The Lymphoma Study Association), Diffuse large B-cell lymphoma.
Shares LYSA (The Lymphoma Study Association), Diffuse large B-cell lymphoma.
Shares LYSA (The Lymphoma Study Association), Diffuse large B-cell lymphoma.
Shares LYSA (The Lymphoma Study Association), Diffuse large B-cell lymphoma.
Shares LYSA (The Lymphoma Study Association), Diffuse large B-cell lymphoma.
Shares LYSA (The Lymphoma Study Association), Diffuse large B-cell lymphoma.
Shares LYSA (The Lymphoma Study Association), Diffuse large B-cell lymphoma.